Effects of incentive spirometer added to standard rehabilitation in previously hospitalized adults with post-COVID-19 condition: a randomized controlled trial
DOI:
https://doi.org/10.2340/jrm.v58.44926Keywords:
Incentive spirometer, Post-Covid-19 syndrome, dyspnoea, peak expiratory flow, quality of life, functional outcomesAbstract
Objective: Post-COVID-19 condition is associated with persistent respiratory symptoms and impaired functional capacity. This study evaluated the effects of adding an incentive spirometer to standard rehabilitation in adults with post-COVID-19 condition, with peak expiratory flow, dyspnoea, and quality of life as the prespecified primary outcomes.
Design: Randomized controlled trial.
Subjects/Patients: Eighty-two previously hospitalized adults diagnosed with post-COVID-19 condition, were randomly assigned to an experimental group (rehabilitation plus incentive spirometer, n = 41) or a control group (rehabilitation alone, n = 41).
Methods: Eight outcomes were assessed at baseline and 1 month, including peak expiratory flow, Medical Research Council dyspnoea scale, EQ-5D-5L, and functional performance tests.
Results: Both groups improve at 1-month follow-up. The experimental group showed greater improvements in peak expiratory flow (between-group difference = 65.85 L/min; 95% CI: 4.35 to 127.35; p = 0.007), and dyspnoea (MRC difference = −1.08; 95% CI: −1.54 to −0.62; p < 0.001) compared with the control group. No significant between-group differences were observed for quality of life or functional performance measures.
Conclusion: Adding incentive spirometry to standard rehabilitation improved peak expiratory flow and reduced dyspnoea in adults with post-COVID-19 condition, supporting its use as a low-cost adjunct for respiratory symptom management.
Downloads
References
Gonzalez-Gerez JJ, Saavedra-Hernandez M, Anarte-Lazo E, Bernal-Utrera C, Perez-Ale M, Rodriguez-Blanco C. Short-term effects of a respiratory telerehabilitation program in confined covid-19 patients in the acute phase: a pilot study. Int J Environ Res Public Health 2021; 18: 7511–7519. DOI: https://doi.org/10.3390/ijerph18147511
WHO Data (2024) WHO COVID-19 dashboard: COVID-19 Cases, World. Available from: https://data.who.int/dashboards/covid19/cases?n=o (accessed February 27, 2026).
WHO Data (2024) WHO COVID-19 dashboard: Number of COVID-19 deaths reported to WHO (cumulative total) [accessed February 27, 2026]. Available from: https://data.who.int/dashboards/covid19/deaths?n=o
Scharf RE, Anaya JM. Post-COVID syndrome in adults – an overview. Viruses 2023; 15: 675–691. DOI: https://doi.org/10.3390/v15030675
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021; 114: 428–442. DOI: https://doi.org/10.1177/01410768211032850
Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev 2023; 12: 88–107. DOI: https://doi.org/10.1186/s13643-023-02250-0
WHO (2025) Clinical management of COVID-19. Living guideline, June 2025 [accessed February 27, 2026]. Available from: https://iris.who.int/server/api/core/bitstreams/d1021eff-f570-4c22-b630-a44bf4267a6c/content
National Academies of Sciences, Engineering, and Medicine. A Long COVID definition: a chronic, systemic disease state with profound consequences. Washington, DC: National Academies Press; 2024.
Hawley HB. Long COVID: clinical findings, pathology, and endothelial molecular mechanisms. Am J Med 2025; 138: 91–97. DOI: https://doi.org/10.1016/j.amjmed.2023.08.008
Sk Abd Razak R, Ismail A, Abdul Aziz AF, Suddin LS, Azzeri A, Sha’ari NI. Post-COVID syndrome prevalence: a systematic review and meta-analysis. BMC Public Health 2024; 24: 1785. DOI: https://doi.org/10.1186/s12889-024-19264-5
Bansal A. Economic burden of long COVID: macroeconomic, cost-of-illness and microeconomic impacts. NPJ Prim Care Respir Med 2025; 35: 53. DOI: https://doi.org/10.1038/s41533-025-00460-8
Koumpias AM, Schwartzman D, Fleming O. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Serv Res 2022; 22: 1010–1024. DOI: https://doi.org/10.1186/s12913-022-08387-3
Maya S, Kahn JG, Lin TK, Jacobs LM, Schmidt LA, Burrough WB, et al. Indirect COVID-19 health effects and potential mitigating interventions: cost-effectiveness framework. PLoS One 2022; 17: e0271523. DOI: https://doi.org/10.1371/journal.pone.0271523
Sapna F, Deepa F, Sakshi F, Sonam F, Kiran F, Perkash RS, et al. Unveiling the mysteries of the long COVID syndrome: exploring the distinct tissue and organ pathologies linked to prolonged COVID-19 symptoms. Cureus 2023; 15: e44588 https://doi.org/10.7759/cureus.44588 DOI: https://doi.org/10.7759/cureus.44588
Tsilinggiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, et al. Laboratory findings and biomarkers in long covid: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int J Mol Sci 2023; 24: 10458. DOI: https://doi.org/10.3390/ijms241310458
Barash M, Ramalingam V. Post-COVID interstitial lung disease and other lung sequelae. Clin Chest Med 2023; 44: 263–277. DOI: https://doi.org/10.1016/j.ccm.2022.11.019
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9: 747–754. DOI: https://doi.org/10.1016/S2213-2600(21)00174-0
van Willigen HDG van, Wynberg E, Verveen A, Dijkstra M, Verkaik BJ, Figaroa OJA, et al. One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset. PLoS One 2023;18: e0290893. DOI: https://doi.org/10.1371/journal.pone.0290893
Christopher DJ, Isaac BTJ, John FB, Shankar D, Samuel P, Gupta R, et al. Impact of post-COVID-19 lung damage on pulmonary function, exercise tolerance and quality of life in Indian subjects. PLoS Glob Public Health 2024; 4: e0002884. DOI: https://doi.org/10.1371/journal.pgph.0002884
Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C. et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 2021; 57: 2003690. DOI: https://doi.org/10.1183/13993003.03690-2020
Zhang S, Bai W, Yue J, Qui L, Zhang C, Xu S. et al. Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors. Sci Rep 2021; 11: 13854. DOI: https://doi.org/10.1038/s41598-021-93191-y
van der Sar - van der Brugge S, Talman S, Boonman - de Winter L, de Mol M, Hoefman E, van Etten RW, et al. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med 2021; 176: 106272–106276. DOI: https://doi.org/10.1016/j.rmed.2020.106272
Lewthwaite H, Byrne A, Brew B, Gibson PG. Treatable traits for long COVID. Respirology 2023; 28: 1005–1022. DOI: https://doi.org/10.1111/resp.14596
Li S, Dai B, Hou Y, Zhang L, Liu J, Hou H, et al. Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Respir Dis 2025; 19: 17534666251323482. DOI: https://doi.org/10.1177/17534666251323482
Bal-Bocheńska M, Wyszyńska J, Kołodziej M. Breathe better after COVID: the impact of a two-week pulmonary rehabilitation program on pulmonary function, inflammatory markers, and quality of life in post-COVID syndrome. J Clin Med 2025; 14: 4533. DOI: https://doi.org/10.3390/jcm14134533
Volckaerts T, Ruttens D, Quadflieg K, Burtin C, Cops D, De Soomer K, et al. Improved functional exercise capacity after primary care pulmonary rehabilitation in patients with long COVID (PuRe-COVID): a pragmatic randomised controlled trial. BMJ Open Respir Res 2025; 12:e003653. DOI: https://doi.org/10.1136/bmjresp-2025-003653
Yue Y, Han X, Chen Q, Dai L, Ai Q, Zhang Z, et al. The effect of pulmonary rehabilitation for post-acute sequelae of SARS-CoV-2 infection in patients: a systematic review and meta-analysis. Front Rehabil Sci 2025; 6:1634351. DOI: https://doi.org/10.3389/fresc.2025.1634351
Franklin E, Anjum F. (2022) Incentive spirometer and inspiratory muscle training [accessed March 17, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572114/
Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care 2011; 56: 1600–1604. DOI: https://doi.org/10.4187/respcare.01471
Hristara-Papadopoulou A, Tsanakas J, Diomou G, Papadopoulou O. Current devices of respiratory physiotherapy. Hippokratia 2008; 12: 211–220.
Abo Elyazed TI, Abd El-Hakim AAE, Saleh OI, Sonbol MMF, Eid HA, Moazen E, et al. Diaphragmatic strengthening exercises for patients with post COVID-19 condition after mild-to-moderate acute COVID-19 infection: a randomized controlled study. J Rehabil Med 2024; 56: jrm25491. DOI: https://doi.org/10.2340/jrm.v56.25491
Loganathan D, Malavika D, Anandhi D, Shirly M, Pugazhendhi S, Jayanthi NN. Effect of incentive spirometry on pulmonary function test in post COVID-19 pneumonia patients. Fizjoterapia Polska 2022; 22: 122–128. DOI: https://doi.org/10.56984/8ZG20AZsV
Kusumawardani RI, Tinduh D, Andriati, Poerwandari D, Marhana IA, Melaniani S. The effectiveness of incentive spirometry exercise on pulmonary function in COVID-19 survivors: a randomised controlled trial study. Bali Med J 2023; 12: 539–544. DOI: https://doi.org/10.15562/bmj.v12i1.3956
Shakerian N, Mofateh R, Niloofar R, Saghazadeh A, Nima R. Potential prophylactic and therapeutic effects of respiratory physiotherapy for COVID-19: respiratory physiotherapy for COVID-19. Acta Biomedica 2021; 92: COVID-10 update.
Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl JP, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect 2022; 28: 955–972. DOI: https://doi.org/10.1016/j.cmi.2022.02.018
Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehab 2020; 66: 480–494. DOI: https://doi.org/10.5606/tftrd.2020.6889
Toor H, Kashyap S, Yau A, Simoni M, Farr S, Salva P, et al. Efficacy of incentive spirometer in increasing maximum inspiratory volume in an out-patient setting. Cureous 2021; 13: e18483. DOI: https://doi.org/10.7759/cureus.18483
Tabor-Gray L, Vasilopoulos T, Plowman EK. Concordant validity of a digital peak cough flow meter to assess voluntary cough strength in individuals with ALS. Dysphagia 2020; 35: 568–573. DOI: https://doi.org/10.1007/s00455-019-10060-7
Papiris SA, Daniil ZD, Malagari K, Kapotsis GE, Sotiropoulou C, Milic-Emili J. et al. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med 2005; 99: 755–761. DOI: https://doi.org/10.1016/j.rmed.2004.10.018
Kontodimopoulos N, Pappa E, Niakas DA, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health 2008; 11: 1162–1169. DOI: https://doi.org/10.1111/j.1524-4733.2008.00356.x
Unnanuntana A, Jarusriwanna A, Nepal S. Validity and responsiveness of Barthel index for measuring functional recovery after hemiarthroplasty for femoral neck fracture. Arch Orthop Trauma Surg 2018; 138: 1671–1677. DOI: https://doi.org/10.1007/s00402-018-3020-z
Meys R, Janssen SMJ, Franssen FME, Vaes AW, Stoffels AAF, van Hees HWH, et al. Test–retest reliability, construct validity and determinants of 6-minute walk test performance in adult patients with asthma. Pulmonology 2023; 29: 486–494. DOI: https://doi.org/10.1016/j.pulmoe.2022.10.011
Kristensen MT, Bloch ML, Jønsson LR, Jakobsen TL. Interrater reliability of the standardized Timed Up and Go Test when used in hospitalized and community-dwelling older individuals. Physiother Res Int 2019; 24: e1769. DOI: https://doi.org/10.1002/pri.1769
Kahraman B, Ozsoy I, Akdeniz B, Ozpelit E, Sevinc C, Acar S, et al. Test–retest reliability and validity of the timed up and go test and 30-second sit to stand test in patients with pulmonary hypertension. Int J Cardiol 2020; 304: 159–163. DOI: https://doi.org/10.1016/j.ijcard.2020.01.028
Karagiannis C, Savva C, Korakakis V, Matheou I, Adamide T, Georgiou A, et al. Test–retest reliability of handgrip strength in patients with chronic obstructive pulmonary disease. COPD 2020; 17: 568–574. DOI: https://doi.org/10.1080/15412555.2020.1808604
Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–586. DOI: https://doi.org/10.1136/thx.54.7.581
Kim J, Duru EE, Weir P, Lee S. Long COVID is associated with decreased quality of life and increased mental disability. COVID 2024; 4: 1719–1730. DOI: https://doi.org/10.3390/covid4110120
Tengker IJ, Mogi TI, Damopolii, CA. Comparison of the effects of incentive spirometry exercises and diaphragm breathing exercises on peak cough flow values Corona virus disease-19. Jurnal Medic Dan Rehabilitasi 2022; 4: 9–21.
Gudivada KK, Tikka SK, Bonthala Y, Miryala SK, Ch RP, Garre S. Association between post-COVID pulmonary dysfunction and new-onset anxiety and depression and the impact of incentive spirometer-based exercises. Prim Care Companion CNS Disord 2023; 25: 23m03490. DOI: https://doi.org/10.4088/PCC.23m03490
Suharti A, Hidayati ERN, Yusviani, HA. Comparative effect of incentive spirometry and diaphragm breathing to functional capacity in COVID-19 patients in an isolated ward. Bali Med J 2022; 11: 1415–1419. DOI: https://doi.org/10.15562/bmj.v11i3.3579
Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health 2021; 18: 5329–5340. DOI: https://doi.org/10.3390/ijerph18105329
Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): a review. Diabetes Metab Syndr 2020; 14:489–496. DOI: https://doi.org/10.1016/j.dsx.2020.04.038
Published
How to Cite
License
Copyright (c) 2026 Marina Kloni, Alexandros Heraclides, Theognosia Panteli, Alexios Klonis, Panagiotis Rentzias, Christos Karagiannis
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.
